Cardiac cath labs can achieve significant radiation dose reductions through focused, collaborative quality improvement (QI) efforts, according to a new analysis published in Circulation: Cardiovascular Interventions.

Edwards Lifesciences’ PASCAL transcatheter valve repair system has gained CE mark approval for treating tricuspid regurgitation (TR).

Until recently, cardiologists’ eyes tended to glaze over at the mention of using 3D printing in their practices. Most believed the costs would be too high for routine use, that the applications and the price tag were better suited to academic applications.

Reported in 2018 by anesthesiologists at the University of Florida College of Medicine in Gainesville, the case suggested a message to TAVR operators: “Vigilance and a high degree of suspicion” are critical for avoiding the potentially severe hemodynamic consequences of HCM associated with aortic stenosis, the authors asserted (J Med Case Rep 2018;18;12[1]:372).

The combination of e-cigarettes containing nicotine and 12 weeks of counseling can help smokers quit more effectively than counseling alone.

Transcatheter aortic valve replacement (TAVR) outcomes have been worse than expected for 11% of healthcare providers in the United States, according to a new analysis of data from 2015 to 2017.

Transcatheter aortic valve replacement (TAVR) procedures with a self-expanding artificial valve are “very viable and safe” for low-risk patients with a bicuspid aortic valve, according to new research that tracked the outcomes of 150 patients.

Of COVID-19 patients who develop serious heart complications, most don’t see this problem until late in the disease’s progression. However, some are turning up with extensive heart inflammation at the outset.

Physicians at St. Michael’s Hospital of Unity Health Toronto in Canada announced this month that they’d completed the world’s first minimally invasive tricuspid valve replacement with success.

Mount Sinai has launched an Adult Congenital Heart Disease Center at Mount Sinai Heart in New York in an attempt to streamline CHD care throughout the life cycle.

A study published in JACC: Cardiovascular Interventions this month found that patients who suffer from migraines may find long-term relief after transcatheter patent foramen ovale closure.

The largest comprehensive study of congenital heart disease to date has revealed that, despite an overall decline in mortality over the past few decades, a child’s odds of surviving a CHD diagnosis hinge on the economic health of their community.